CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
5 research outputs found
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
Author
A Malmstrom
C Nicolaides
+60Â more
CJ van Moorsel
D diGioia
D Laessig
D Loesch
E Kettner
EA Wist
EL Kaplan
EM Ciruelos
FL Nasr
G Achanta
G Gitsch
GJ Peters
GP Stathopoulos
H Fuentes
H J Hurtz
H J Stemmler
H Tesch
H W Tessen
HJ Stemmler
HK Chew
I Chitapanarux
I Somali
IH Park
JA Ajani
JA Oshaughnessy
JA Silva
JH Ahn
JH Kim
JH Seo
K Haider
K Kolaric
M Blackstein
M Degardin
M Spielmann
N Batista
N Koshy
O Brudler
PA Burch
R Andres
R Simon
R Valenza
RA Nagourney
RA Nagourney
RK Gregory
S Jones
S Modi
S Rösel
S Shehata
SH Lee
T Brodowicz
TZ Mohran
V Heinemann
V Heinemann
V Heinemann
V Heinemann
W Abenhardt
W Brugger
W Freier
W Jonat
Z. Alauddin
Publication venue
Nature Publishing Group
Publication date
Field of study
Get PDF
Crossref
PubMed Central
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Author
A. Scharl
Achanta G
+40Â more
Ahn JH
Alauddin A
B. Kalischefski
B. Weber
Batista N
Burch PA
Carmichael J
Chitapanarux I
D. Laessig
F. Melchert
Fuentes H
G. Morack
Go RS
H. Kö
H. Meerpohl
H.J. Stemmler
Heinemann V
Iaffaioli RV
Kolaric K
Latini L
M. Stauch
Martin M
Martin M
Modi S
Mohran TZ
Moura GL
Nagourney RA
Nasr FL
O'Brien ME
Oshaughnessy JA
P. Maubach
P.A. Fasching
Peters GJ
Seo JH
Silva JA
Smorenburg CH
Stemmler HJ
U. Vehling-Kaiser
V. Heinemann
van Moorsel CJ
Publication venue
'S. Karger AG'
Publication date
01/01/2007
Field of study
No full text
Crossref
A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer
Author
Ahn JH
Ali I. Shamseddine
+42Â more
Anton A
Aref Chehal
Azzam Dandashi
Bernard A
Biganzoli L
Bruno S
Burstein HJ
Costanza ME
Danova M
Demiray M
Ershler WB
Fulton B
Fumoleau P
Fumoleau P
Garcia-Conde J
Hanan R. Yassine
Henderson IC
Henderson IC
Jones SE
Khayat D
Kolaric K
Mahmoud Wehbeh
Martin M
Marty M
Maya Charafeddine
Mayordomo JI
Mohamad J. Khalifeh
Mohran TZ
Morabito A
Moussa Dheiny
Nabholtz JM
Nagi S. El-Saghir
Nizar Bitar
Paridaens R
Rahif Jalloul
Romero Acuna L
Shamseddine A
Shamseddine AI
Sledge
Weber BL
Zaher K. Otrock
Zeina Abdel-Khalek
Publication venue
'S. Karger AG'
Publication date
Field of study
No full text
Crossref
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
Author
A Awada
A Sandler
+49Â more
AA Adjei
AA Adjei
AA Adjei
AA Adjei
AG Taveras
C Theodore
Cindy L. O’Bryant
D Gallardo
E Wang
EK Rowinsky
F Caponigro
FA Eskens
FA Shepherd
G Colucci
GJ Peters
GV Scagliotti
H Fuentes
HR Ashar
J Head
J Sun
JB Gibbs
JE Rosenberg
JH Seo
KS Smalley
L Crino
L Crino
L Gore
Laura Q. M. Chow
Lia Gore
M Liu
M Loprevite
Mark Morrow
Mary Kay Schultz
Michele Basche
MM Bradford
NE Ready
P Haluska
RA Nagourney
RK Ngan
S. Gail Eckhardt
SK Gupta
SR Johnston
Stacy Grolnic
T Le Chevalier
T Petit
TZ Mohran
V Adamo
V Heinemann
WZ Gu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer
Author
Ahn JH
Akamatsu K
+184Â more
Ali I. Shamseddine
Amoroso D
Aoyama H
Arteaga CL
Athanassiades P
Bajorin D
Barker LJ
Bitran JD
Bonnefoi H
Booser DJ
Boulikas T
Bozionelou V
Braybrooke JP
Burch PA
Burris
Carey LA
Cartei G
Casper ES
Casper ES
Caussanel JP
Ceci G
Chan D
Chew HK
Cocconi G
Cocconi G
Colozza M
Cortes JE
Coskun U
Cox EB
Crown J
Decatris MP
Decatris MP
Delozier T
Deltetto F
Dogliotti L
Donadio M
Durand RE
Eisen T
Evers B
Ezzat A
Fadi S. Farhat
Fan Y
Farhat F
Fernandez Hidalgo O
Forastiere AA
Fornasiero A
Fountzilas G
Fountzilas G
Fountzilas G
Fountzilas G
Franciosi V
Frasci G
Fried G
Fuentes H
Fumoleau P
Galanski M
Garrone O
Garufi C
Gebbia V
Gelmon KA
Gelmon KA
Giaccone G
Gourley C
Gunel N
Heinemann V
Hoadley KA
Hsu C
Hsu C
Iaffaioli RV
Icli F
Icli F
Jones AL
Kakolyris S
Kim JH
Klaassen U
Kochupillai V
Kolaric K
Kolaric K
Koshy N
Kosmas C
Kouroussis C
Koyama H
Krockenberger M
Krook JE
Kucuk O
Kurata T
Laessig D
Lin YC
Lluch A
Loesch D
Loesch D
Maiche AG
Maisano R
Mao W
Martin M
Martino S
Mathe G
Mavroudis D
Mechl Z
Meisner DJ
Mohran TZ
Moulder S
Mustacchi G
Nabholtz JM
Nagourney RA
Nagourney RA
Nasr FL
Nielsen D
Nole F
Oksuzoglu B
Oliveras-Ferraros C
Oster MW
Ostrow S
O’Brien ME
O’Shaughnessy J
O’Shaughnessy J
Palacio I
Park SH
Pegram MD
Pegram MD
Pegram MD
Perez EA
Perez EA
Perez EA
Peters GJ
Petit T
Pietras RJ
Polyzos A
Qu G
Ramnath N
Ray-Coquard I
Remick SC
Robert N
Ron IG
Rosati G
Rottenberg S
Ruiz M
Sanchez-Escribano Morcuende R
Schabel
Semiglazova T
Seo JH
Shamseddine A
Shamseddine AI
Shamseddine AI
Sharma RA
Sirohi B
Sledge
Smith
Somali I
Spaeth D
Sparano JA
Spielmann M
Staudacher L
Stemmler HJ
Szatkowska L
Taguchi T
Tanis BC
Tanis BC
Tas F
Theriault RL
Theriault RL
Thurlimann B
Thuss-Patience PC
Tkaczuk KH
Tutt A
Tzekova V
Urruticoechea A
Valachis A
van der Gaast A
Vassilomanolakis M
Vassilomanolakis M
Vassilomanolakis M
Vermorken JB
Verusio C
Vinolas N
Wang Y
Wang YJ
Wasserheit C
Xu BH
Yap HY
Yardley DA
Zaniboni A
Zelek L
Zheng H
Publication venue
'S. Karger AG'
Publication date
Field of study
No full text
Crossref